Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Liquidia Corporation - Common Stock
(NQ:
LQDA
)
12.90
-1.23 (-8.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Liquidia Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Petco, AppLovin, Dave & Buster's And Other Big Stocks Moving Higher On Wednesday
September 11, 2024
Via
Benzinga
Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement
September 11, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
September 06, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
These Analysts Cut Their Forecasts On Liquidia
August 20, 2024
Via
Benzinga
Why Liquidia Corporation Shares Are Moving Lower Monday
August 19, 2024
Liquidia announced that the Food and Drug Administration granted tentative approval of YUTREPIA.
Via
Benzinga
Expert Ratings For Liquidia
August 08, 2024
Via
Benzinga
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
August 29, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Liquidia to Present at Upcoming Investor Conferences
August 28, 2024
From
Liquidia Corporation
Via
GlobeNewswire
LIQUIDIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm
August 27, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Expert Outlook: Liquidia Through The Eyes Of 5 Analysts
July 18, 2024
Via
Benzinga
Forecasting The Future: 5 Analyst Projections For Liquidia
June 25, 2024
Via
Benzinga
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Liquidia Corporation (LQDA)
August 27, 2024
From
Kirby McInerney LLP
Via
Business Wire
Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD
August 22, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Jim Cramer Praises PayPal CEO Alex Chriss: 'Financial Techs Have Come Back In Style'
August 21, 2024
PayPal CEO Alex Chriss "is a very good manager," Cramer said. Plus: AST SpaceMobile, Flutter Entertainment and more.
Via
Benzinga
Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday
August 20, 2024
Via
Benzinga
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
August 19, 2024
Via
Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
August 19, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38%
August 19, 2024
The company is hoping to launch a drug that rivals United Therapeutics' Tyvaso DPI.
Via
Investor's Business Daily
LQDA Investors Have Opportunity to Join Liquidia Corporation Securities Fraud Investigation with the Schall Law Firm
August 19, 2024
From
The Schall Law Firm
Via
Business Wire
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
August 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Liquidia, Shake Shack And Other Big Stocks Moving Lower In Monday's Pre-Market Session
August 19, 2024
Via
Benzinga
U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
August 19, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions
August 16, 2024
From
Liquidia Corporation
Via
GlobeNewswire
LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q2 2024
August 07, 2024
LQDA stock results show that Liquidia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 07, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024
July 31, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)
June 18, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 03, 2024
Via
Benzinga
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
June 03, 2024
Liquidia stock retook its 50-day line Monday on a U.S. judge's ruling on a patent dispute with fellow biotech company United Therapeutics.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.